| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |